Glass Lewis Backs Dissident in HC2
Board Battle
The proxy adviser recommended
shareholders support ex-Third Point analyst Michael Gorzynski’s effort
to replace the company’s entire six-person board and oust founder and
CEO Philip Falcone.
By Ronald
Orol
Updated on April 30, 2020, 10:59 AM ET
Philip Falcone, HC2 CEO |
Proxy adviser Glass,
Lewis & Co. LLC has urged shareholders of HC2
Holdings Inc. (HCHC) to back a complete board takeover effort
by ex-Third
Point LLC analyst Michael Gorzynski, in a major blow to the
miniconglomerate’s founder and CEO Philip
Falcone.
The recommendation, published Wednesday, April 29, and obtained by The
Deal Thursday, represents a second consecutive negative recommendation
for Falcone. Institutional
Shareholder Services Inc. earlier
this month urged investors to back three of six dissident
directors. Both reports, however, urge shareholders to vote Falcone
off of HC2's board.
The insurgent manager wants Falcone removed from his role as CEO. It
also wants the company to focus on its core assets, including
construction unit DBM
Global and insurance outfits Continental
Insurance Group and Continental General Insurance Co., while
divesting other units. In addition, Gorzynski wants to become interim
CEO in Falcone’s stead. HC2 has business operations in construction,
marine services, insurance and other sectors.
“After having reviewed the background and qualifications of the
dissident nominees, we are of the opinion that the dissident has
presented a compelling slate of qualified independent nominees with
experience," Glass Lewis said in its report.
Gorzynski, manager of MG Capital Management LP, has an unconventional
approach to electing his dissident director candidates. Instead of
waiting for an annual meeting, the activist investor is employing a
written consent solicitation director battle. Consents for incumbent
and dissident director candidates are due to be tallied and delivered
to the company’s proxy solicitor by May 12.
The two major proxy advisers differ as to whether Gorzynski should get
to install himself as interim CEO following the director election.
Glass Lewis appeared supportive of Gorzynski’s commitment not to
receive pay if he were appointed interim CEO, as the company would
also conduct a hunt for a full-time replacement through an external
search process. However, ISS suggested that shareholders may have some
reservations regarding Gorzynski’s ability as interim CEO “given his
lack of experience as a public company executive or director.”
Glass Lewis focused much of its report in support of Gorzynski’s plan
to cut costs, noting that he plans to reduce executive compensation
and implement a 50% pay cut in director fees, with possible additional
cuts to follow after a review of the businesses.
Both ISS and Glass Lewis were critical of Falcone. Glass Lewis said
that the dissident has “highlighted valid concerns” about Falcone’s
personal legal matters “in the context of potential reputational harm
to certain of the company’s operating businesses, as well as efforts
by a majority of the directors in prior years to marginalize the
company's common shareholders.”
ISS pointed to “refinancing missteps, questionable accounting
decisions and Falcone's prior litigious history” as reasons to remove
him from the board.
In February, a lawsuit filed by Melody
Business Financial LLC with the New York State Supreme Court
in Manhattan alleged Falcone and other affiliates defaulted on
obligations to repay loans between 2013 and 2017 and inappropriately
sold some pledged collateral including artworks produced by Edgar
Degas and Andy Warhol. Melody seeks more than $65.8 million, and a
court last year reportedly ordered HC2 to hold back some of Falcone’s
wages to satisfy unpaid obligations after he was ordered to pay unpaid
taxes in New York.
The City of New York recently obtained a levy to collect the $2.5
million unpaid balance of its $2.7 million judgment against Falcone.
It is unclear whether Falcone's stake in HC2 would be affected by the
lawsuits with creditors such as Melody.
A Feb. 14 13D filing from Falcone shows the HC2 CEO owns 17% of the
company, or about 9 million shares. According to the filing, Falcone
owns 1.3 million shares of which he "he has the sole power to vote or
dispose." Beyond those shares, he has options that could bring his
total to closer to 17% of the company's stock.
Even with the recommendations, MG Capital will have a tough time
convincing some big shareholders not to back Falcone.
Seeking to appease disgruntled investors, HC2 announced April 21 it
was installing a new director, Lancer Capital LLC’s Avram Glazer, as
board chairman. Lancer owns a 5.3% HC2 stake. HC2’s interim chairman,
Warren Gfeller, has described Glazer as an “independent and
high-quality nominee.” However, Glazer has connections to Gfeller,
Falcone and HC2 that suggest he isn’t independent.
In addition, another activist, Julian Singer, a 6.4% holder, reported
earlier this month that he supported Glazer’s nomination and that he
wouldn’t back MG Capital’s campaign.
|